Drug Topics

APRIL 9, 2025

The drug shows a decrease in proteinuria and is well tolerated and safe, including for Black patients with chronic kidney disease.

371

371

STAT

APRIL 9, 2025

A national public health organization is calling for Health Secretary Robert F. Kennedy Jr. to resign the federal post he assumed just weeks ago, citing “implicit and explicit bias and complete disregard for science.” Georges Benjamin, executive director of the American Public Health Association, said in a statement on Wednesday that concerns raised during Kennedy’s confirmation hearing last month have been realized, followed by massive reductions in staff at key health agen

145

145

Drug Topics

APRIL 9, 2025

In an update to the Journal of Pain Researchs formative meta-analysis on pain management in the US, researchers focused on the racial and ethnic disparities in access to pain treatment.

341

341

STAT

APRIL 9, 2025

Amid the hard-to-follow cutbacks at the U.S. Food and Drug Administration, a little-known but important office was eliminated — and the implications will be felt not only by drugmakers, but consumers. The Division of Policy Development in the Office of Generic Drug Policy, which was created more than a decade ago, was responsible for a host of activities that were central to ensuring generic drugs were approved properly for the American market.

FDA 118

FDA 118

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

APRIL 9, 2025

Expert on pain medicine, Mark Garofoli, PharmD, BCGP, CPE, joined Drug Topics to discuss trends in the safety and efficacy of OTC pain medications and what products patients often seek at the pharmacy.

281

281

The Checkup by Singlecare

APRIL 9, 2025

People with Type 2 Diabetes have many treatment options these days, though not all are covered by insurance. Ozempic is a prescription weekly injection manufactured by Novo Nordisk. It is often covered by insurance when prescribed for diabetes (not weight loss ). However, not all insurance plans cover Ozempic and when it is covered, the coverage amount may vary by provider and plan.

Insurance Coverage 69

Insurance Coverage Insurance Pharmacy Program Director Labelling 69

The Checkup by Singlecare

APRIL 9, 2025

Atorvastatin , a medication in the statin drug class , is prescribed to treat high cholesterol. Available in both tablet and liquid form, atorvastatin blocks the enzyme needed to make low-density lipoprotein (LDL) cholesterol (aka bad cholesterol) in the liver. Since high cholesterol can cause heart attacks and strokes, and this risk increases as people age, older adults may be more likely to need lipid-lowering agents like atorvastatin.

Labelling 59

Labelling Medication Labelling FDA 59

Drug Topics

APRIL 9, 2025

Micah Cost, PharmD, MS, CAE, CEO of the Pharmacy Quality Alliance, hosted the keynote session at the Total Pharmacy Solutions Summit Spring 2025 event.

247

247

PharmaVoice

APRIL 9, 2025

“There will be a ChatGPT moment for biotechnology,” a bipartisan commission wrote in the new report, which calls for the U.S. to invest at least $15 billion into the sector over the next five years.

130

130

Drug Topics

APRIL 9, 2025

Data from the HERCULES phase 3 trial were presented at the 2025 Annual Meeting for the American Academy of Neurology for non-relapsing secondary progressive multiple sclerosis.

247

247

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Marketing Network

APRIL 9, 2025

Imagine launching a breakthrough therapybut the right people never see it. In a world dominated by digital conversations, failing to master pharma digital marketing is no longer an optionits a risk to market performance. Pharma marketers today must navigate not only consumer expectations but also a tightly regulated environment. The stakes are high, but so are the opportunities.

FDA 52

FDA 52

Drug Topics

APRIL 9, 2025

Pharmacists are well positioned to screen for diversion, monitor for opioid use disorder, and educate patients on opioid-related risks.

216

216

Pharmacy Times

APRIL 9, 2025

Huntington disease (HD) has no curative treatments, therefore, there is a great need for therapies that can reduce or slow the progression of symptoms.

123

123

The Checkup by Singlecare

APRIL 9, 2025

Depakote is a brand-name anticonvulsant medication that comes in an extended-release tablet , delayed-release tablet , and delayed-release capsule. Also referred to by its generic name divalproex sodium Depakote is used to treat bipolar disorder and certain types of seizures caused by epilepsy. Its also prescribed to prevent migraine headaches. Without insurance, Depakote costs $769 for 90, 500 mg delayed-release tablets.

Insurance 52

Insurance Mail-Order Pharmacies Insurance Coverage Dosage 52

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

PharmaVoice

APRIL 9, 2025

The top 20 pharma companies are focusing on novel drugs, innovative dealmaking and playing to their strengths to bolster R&D ROI.

114

114

Pharmacy Times

APRIL 9, 2025

Conventional wisdom on growing old is getting a second look.

101

101

pharmaphorum

APRIL 9, 2025

The US is close to falling behind China in biotech and the government should spend a minimum of $15bn over the next five years to support the sector.

100

100

Pharmacy Times

APRIL 9, 2025

Mya Tran, PharmD, BCOP, offers insights for navigating the complex treatment landscape for non-small cell lung cancer.

86

86

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

APRIL 9, 2025

Researchers in the UK have developed a lung cancer cell line that they believe could be an important new tool for the discovery of new therapies.

86

86

Pharmacy Times

APRIL 9, 2025

Monetary incentives to receive a COVID-19 vaccine at a public vaccination event may have invertedly turned away others from receiving a booster, emphasizing the importance of recognizing spillover in trials addressing vaccine hesitancy.

Vaccines 73

Vaccines 73

pharmaphorum

APRIL 9, 2025

The FDA has approved Bristol Myers Squibb's Opdivo and Yervoy as first-line therapy for patients with a particular form of colorectal cancer

FDA 80

FDA 80

Fierce Healthcare

APRIL 9, 2025

The Department of Government Efficiency is moving a provider enrollment system in-house, despite scrubbing mention of an outside contract termination.

72

72

pharmaphorum

APRIL 9, 2025

Jazz Pharma has offered to pay $145m to settle claims it paid to prevent generic versions of its narcolepsy drug Xyrem from reaching the US market.

66

66

Fierce Healthcare

APRIL 9, 2025

Google Cloud continues to quickly build out its generative AI capabilities and is advancing technology for the adoption and use of AI agents to automate tasks and collaborate across organizations.

70

70

Pharmacy Times

APRIL 9, 2025

Cases against PBMs and Big Insurers could be bogged by procedural hurdles if SCOTUS sides with petitioner, NCPA says.

Insurance 65

Insurance 65

Pharmaceutical Commerce

APRIL 9, 2025

How can stakeholders prepare for changing therapy requirements?

59

59

Pharmacy Times

APRIL 9, 2025

Michael Arnold, PharmD, discussed the role of oncology pharmacists in enhancing biomarker testing for patients with metastatic colorectal cancer.

65

65

Pharmaceutical Commerce

APRIL 9, 2025

Steffen Lang, president, operations, executive committee member, Novartis, discusses the premise of a keynote session on reimagining operations.

59

59

Pharmacy Times

APRIL 9, 2025

Pharmacists play a key role in educating patients and prescribers on the selection, use, and management of GLP-1 receptor agonists in diabetes care.

65

65

Pharmaceutical Commerce

APRIL 9, 2025

A keynote presentation describes how supply chain visibility should rely on digital capabilities.

59

59

Pharmacy Times

APRIL 9, 2025

Nilufer Ertekin-Taner contrasts current one-size-fits-all Alzheimer disease treatments with the promise of precision medicine and emphasizes the vital role of collaborative, multidisciplinary care.

65

65

Pharmaceutical Commerce

APRIL 9, 2025

The latest news for pharma industry insiders.

59

59

Fierce Healthcare

APRIL 9, 2025

This week on "Podnosis," Senior Writer Paige Minemyer chats with Jason Oberfest, vice president of healthcare at Oura, to discuss how the company is approaching its push into healthcare.

54

54